Search

Search Results
Results 7391 - 7400 of 17271 for Active treatment
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.
  • Drug - 11 May 2026
    Consumer Medicine Information (CMI) about Tecfidera intended for persons living in Australia.
  • News - 11 May 2026
    A fluid that women with advanced ovarian cancer know all too well - ascites, the buildup of liquid in the belly - may be doing more than causing discomfort.
  • News - 11 May 2026
    Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.
  • News - 11 May 2026
    A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can return many years after successful treatment.
  • News - 7 May 2026
    Ahead of World Lupus Day on May 10, new research from the Garvan Institute of Medical Research and UNSW Sydney helps explain why women are significantly more likely to be diagnosed with an autoimmune...
  • Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Fludara Oral intended for persons living in Australia.
  • Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Winrevair intended for persons living in Australia.
  • Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Vidaza intended for persons living in Australia.
  • Drug - 5 May 2026
    Consumer Medicine Information (CMI) about Evoltra intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.